Priority review for Welireg is based on data from the Phase II LITESPARK-015 trial, which showed promising response rates in ...

The government agency says X no longer suits its communication needs.

Approval was based on results from multiple studies, which demonstrated a slowing of cognitive decline in patients with ...

A surge in biotech startup out-licensing deals from the country are paving the way for increased IPO and M&A activities.

Campaign encourages the use of low-dose aspirin to help reduce the risk of preeclampsia and the complications that come with ...

Veeva’s vice president of commercial strategy discusses how streamlining their processes with a single goal in mind can ...

Under terms of the deal, AbbVie will provide Neomorph with an upfront payment and the potential to earn up to $1.64 billion ...

CIII nasal spray, marking the first monotherapy to be approved for adults with treatment-resistant depression (TRD).

Trial findings show long-term recurrence-free survival in patients with low-grade upper tract urothelial cancer treated with ...

As part of the regulatory action, memantine/donepezil extended-release capsules have been granted a 180-day exclusivity in ...

Application is supported by results from the DEVOTE study, which suggested that two doses of Spinraza (nusinerse) 50 mg taken ...

Cary Claiborne, CEO, Adial Pharmaceuticals, discusses AD04’s development timeline and next steps towards approval for alcohol ...